カテゴリー： 世界, 医療/バイオ, LP Information

世界のソホスブビル錠剤市場予測 2023年-2029年

【英語タイトル】Global Sofosbuvir Tablets Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC10546）・商品コード：LP23DC10546
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のソホスブビル錠剤市場」は、過去の販売実績から2022年の世界のソホスブビル錠剤の総販売量を検討し、2023年から2029年の予測されるソホスブビル錠剤の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のソホスブビル錠剤の市場規模を掲載し、XXX百万米ドル規模の世界のソホスブビル錠剤市場の詳細な分析を提供します。本インサイトレポートは、世界のソホスブビル錠剤業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のソホスブビル錠剤市場における各社の独自のポジションをより深く理解するために、ソホスブビル錠剤製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のソホスブビル錠剤市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。ソホスブビル錠剤の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。ソホスブビル錠剤の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。ソホスブビル錠剤のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

ソホスブビル錠剤の世界主要メーカーとしては、Gilead Sciences, Inc.、 Shandong Shibo Jindu Pharmaceutical Co., Ltd.、 CTTQ、 Sihuan Pharmaceutical Holdings Group Ltd.、 Cspc Ouyi Pharmaceutical Co., Ltd.、 Beijing Kawin Technology Share-Holding Co., Ltd.、 DM Pharma、 Wellona Pharma、 Mylan Laboratoriesなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のソホスブビル錠剤市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではソホスブビル錠剤市場をセグメンテーションし、種類別 (先発医薬品、ジェネリック医薬品)、用途別 (病院、診療所、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：先発医薬品、ジェネリック医薬品

・用途別区分：病院、診療所、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のソホスブビル錠剤市場の10年間の市場状況・展望は？
・世界および地域別に見たソホスブビル錠剤市場成長の要因は何か？
・ソホスブビル錠剤の市場機会はエンドマーケットの規模によってどのように変化するのか？
・ソホスブビル錠剤のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：ソホスブビル錠剤の年間販売量2018-2029、地域別現状・将来分析
・ソホスブビル錠剤の種類別セグメント：先発医薬品、ジェネリック医薬品
・ソホスブビル錠剤の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・ソホスブビル錠剤の用途別セグメント：病院、診療所、その他
・ソホスブビル錠剤の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のソホスブビル錠剤市場
・企業別のグローバルソホスブビル錠剤市場データ：2018-2023年の年間販売量、市場シェア
・企業別のソホスブビル錠剤の年間売上：2018-2023年の売上、市場シェア
・企業別のソホスブビル錠剤販売価格
・主要企業のソホスブビル錠剤生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

ソホスブビル錠剤の地域別レビュー
・地域別のソホスブビル錠剤市場規模2018-2023：年間販売量、売上
・主要国別のソホスブビル錠剤市場規模2018-2023：年間販売量、売上
・南北アメリカのソホスブビル錠剤販売の成長
・アジア太平洋のソホスブビル錠剤販売の成長
・ヨーロッパのソホスブビル錠剤販売の成長
・中東・アフリカのソホスブビル錠剤販売の成長

南北アメリカ市場
・南北アメリカの国別のソホスブビル錠剤販売量、売上（2018-2023）
・南北アメリカのソホスブビル錠剤の種類別販売量
・南北アメリカのソホスブビル錠剤の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のソホスブビル錠剤販売量、売上（2018-2023）
・アジア太平洋のソホスブビル錠剤の種類別販売量
・アジア太平洋のソホスブビル錠剤の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のソホスブビル錠剤販売量、売上（2018-2023）
・ヨーロッパのソホスブビル錠剤の種類別販売量
・ヨーロッパのソホスブビル錠剤の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のソホスブビル錠剤販売量、売上（2018-2023）
・中東・アフリカのソホスブビル錠剤の種類別販売量
・中東・アフリカのソホスブビル錠剤の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・ソホスブビル錠剤の製造コスト構造分析
・ソホスブビル錠剤の製造プロセス分析
・ソホスブビル錠剤の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・ソホスブビル錠剤の主要なグローバル販売業者
・ソホスブビル錠剤の主要なグローバル顧客

地域別のソホスブビル錠剤市場予測レビュー
・地域別のソホスブビル錠剤市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・ソホスブビル錠剤の種類別市場規模予測
・ソホスブビル錠剤の用途別市場規模予測

主要企業分析
Gilead Sciences, Inc.、 Shandong Shibo Jindu Pharmaceutical Co., Ltd.、 CTTQ、 Sihuan Pharmaceutical Holdings Group Ltd.、 Cspc Ouyi Pharmaceutical Co., Ltd.、 Beijing Kawin Technology Share-Holding Co., Ltd.、 DM Pharma、 Wellona Pharma、 Mylan Laboratories
・企業情報
・ソホスブビル錠剤製品
・ソホスブビル錠剤販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Sofosbuvir Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Sofosbuvir Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Sofosbuvir Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Sofosbuvir Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Sofosbuvir Tablets players cover Gilead Sciences, Inc., Shandong Shibo Jindu Pharmaceutical Co., Ltd., CTTQ, Sihuan Pharmaceutical Holdings Group Ltd., Cspc Ouyi Pharmaceutical Co., Ltd., Beijing Kawin Technology Share-Holding Co., Ltd., DM Pharma, Wellona Pharma and Mylan Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)’ newest research report, the “Sofosbuvir Tablets Industry Forecast” looks at past sales and reviews total world Sofosbuvir Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Sofosbuvir Tablets sales for 2023 through 2029. With Sofosbuvir Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sofosbuvir Tablets industry.
This Insight Report provides a comprehensive analysis of the global Sofosbuvir Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Sofosbuvir Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sofosbuvir Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sofosbuvir Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sofosbuvir Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Sofosbuvir Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Original Drugs
Generic Drugs
Segmentation by application
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Gilead Sciences, Inc.
Shandong Shibo Jindu Pharmaceutical Co., Ltd.
CTTQ
Sihuan Pharmaceutical Holdings Group Ltd.
Cspc Ouyi Pharmaceutical Co., Ltd.
Beijing Kawin Technology Share-Holding Co., Ltd.
DM Pharma
Wellona Pharma
Mylan Laboratories
Key Questions Addressed in this Report
What is the 10-year outlook for the global Sofosbuvir Tablets market?
What factors are driving Sofosbuvir Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Sofosbuvir Tablets market opportunities vary by end market size?
How does Sofosbuvir Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Sofosbuvir Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Sofosbuvir Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Sofosbuvir Tablets by Country/Region, 2018, 2022 & 2029
2.2 Sofosbuvir Tablets Segment by Type
2.2.1 Original Drugs
2.2.2 Generic Drugs
2.3 Sofosbuvir Tablets Sales by Type
2.3.1 Global Sofosbuvir Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Sofosbuvir Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Sofosbuvir Tablets Sale Price by Type (2018-2023)
2.4 Sofosbuvir Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Sofosbuvir Tablets Sales by Application
2.5.1 Global Sofosbuvir Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Sofosbuvir Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Sofosbuvir Tablets Sale Price by Application (2018-2023)
3 Global Sofosbuvir Tablets by Company
3.1 Global Sofosbuvir Tablets Breakdown Data by Company
3.1.1 Global Sofosbuvir Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Sofosbuvir Tablets Sales Market Share by Company (2018-2023)
3.2 Global Sofosbuvir Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Sofosbuvir Tablets Revenue by Company (2018-2023)
3.2.2 Global Sofosbuvir Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Sofosbuvir Tablets Sale Price by Company
3.4 Key Manufacturers Sofosbuvir Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Sofosbuvir Tablets Product Location Distribution
3.4.2 Players Sofosbuvir Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Sofosbuvir Tablets by Geographic Region
4.1 World Historic Sofosbuvir Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Sofosbuvir Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Sofosbuvir Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Sofosbuvir Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Sofosbuvir Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Sofosbuvir Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Sofosbuvir Tablets Sales Growth
4.4 APAC Sofosbuvir Tablets Sales Growth
4.5 Europe Sofosbuvir Tablets Sales Growth
4.6 Middle East & Africa Sofosbuvir Tablets Sales Growth
5 Americas
5.1 Americas Sofosbuvir Tablets Sales by Country
5.1.1 Americas Sofosbuvir Tablets Sales by Country (2018-2023)
5.1.2 Americas Sofosbuvir Tablets Revenue by Country (2018-2023)
5.2 Americas Sofosbuvir Tablets Sales by Type
5.3 Americas Sofosbuvir Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sofosbuvir Tablets Sales by Region
6.1.1 APAC Sofosbuvir Tablets Sales by Region (2018-2023)
6.1.2 APAC Sofosbuvir Tablets Revenue by Region (2018-2023)
6.2 APAC Sofosbuvir Tablets Sales by Type
6.3 APAC Sofosbuvir Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Sofosbuvir Tablets by Country
7.1.1 Europe Sofosbuvir Tablets Sales by Country (2018-2023)
7.1.2 Europe Sofosbuvir Tablets Revenue by Country (2018-2023)
7.2 Europe Sofosbuvir Tablets Sales by Type
7.3 Europe Sofosbuvir Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Sofosbuvir Tablets by Country
8.1.1 Middle East & Africa Sofosbuvir Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Sofosbuvir Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Sofosbuvir Tablets Sales by Type
8.3 Middle East & Africa Sofosbuvir Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Sofosbuvir Tablets
10.3 Manufacturing Process Analysis of Sofosbuvir Tablets
10.4 Industry Chain Structure of Sofosbuvir Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Sofosbuvir Tablets Distributors
11.3 Sofosbuvir Tablets Customer
12 World Forecast Review for Sofosbuvir Tablets by Geographic Region
12.1 Global Sofosbuvir Tablets Market Size Forecast by Region
12.1.1 Global Sofosbuvir Tablets Forecast by Region (2024-2029)
12.1.2 Global Sofosbuvir Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Sofosbuvir Tablets Forecast by Type
12.7 Global Sofosbuvir Tablets Forecast by Application
13 Key Players Analysis
13.1 Gilead Sciences, Inc.
13.1.1 Gilead Sciences, Inc. Company Information
13.1.2 Gilead Sciences, Inc. Sofosbuvir Tablets Product Portfolios and Specifications
13.1.3 Gilead Sciences, Inc. Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Gilead Sciences, Inc. Main Business Overview
13.1.5 Gilead Sciences, Inc. Latest Developments
13.2 Shandong Shibo Jindu Pharmaceutical Co., Ltd.
13.2.1 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Company Information
13.2.2 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Sofosbuvir Tablets Product Portfolios and Specifications
13.2.3 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Main Business Overview
13.2.5 Shandong Shibo Jindu Pharmaceutical Co., Ltd. Latest Developments
13.3 CTTQ
13.3.1 CTTQ Company Information
13.3.2 CTTQ Sofosbuvir Tablets Product Portfolios and Specifications
13.3.3 CTTQ Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 CTTQ Main Business Overview
13.3.5 CTTQ Latest Developments
13.4 Sihuan Pharmaceutical Holdings Group Ltd.
13.4.1 Sihuan Pharmaceutical Holdings Group Ltd. Company Information
13.4.2 Sihuan Pharmaceutical Holdings Group Ltd. Sofosbuvir Tablets Product Portfolios and Specifications
13.4.3 Sihuan Pharmaceutical Holdings Group Ltd. Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sihuan Pharmaceutical Holdings Group Ltd. Main Business Overview
13.4.5 Sihuan Pharmaceutical Holdings Group Ltd. Latest Developments
13.5 Cspc Ouyi Pharmaceutical Co., Ltd.
13.5.1 Cspc Ouyi Pharmaceutical Co., Ltd. Company Information
13.5.2 Cspc Ouyi Pharmaceutical Co., Ltd. Sofosbuvir Tablets Product Portfolios and Specifications
13.5.3 Cspc Ouyi Pharmaceutical Co., Ltd. Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Cspc Ouyi Pharmaceutical Co., Ltd. Main Business Overview
13.5.5 Cspc Ouyi Pharmaceutical Co., Ltd. Latest Developments
13.6 Beijing Kawin Technology Share-Holding Co., Ltd.
13.6.1 Beijing Kawin Technology Share-Holding Co., Ltd. Company Information
13.6.2 Beijing Kawin Technology Share-Holding Co., Ltd. Sofosbuvir Tablets Product Portfolios and Specifications
13.6.3 Beijing Kawin Technology Share-Holding Co., Ltd. Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Beijing Kawin Technology Share-Holding Co., Ltd. Main Business Overview
13.6.5 Beijing Kawin Technology Share-Holding Co., Ltd. Latest Developments
13.7 DM Pharma
13.7.1 DM Pharma Company Information
13.7.2 DM Pharma Sofosbuvir Tablets Product Portfolios and Specifications
13.7.3 DM Pharma Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 DM Pharma Main Business Overview
13.7.5 DM Pharma Latest Developments
13.8 Wellona Pharma
13.8.1 Wellona Pharma Company Information
13.8.2 Wellona Pharma Sofosbuvir Tablets Product Portfolios and Specifications
13.8.3 Wellona Pharma Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Wellona Pharma Main Business Overview
13.8.5 Wellona Pharma Latest Developments
13.9 Mylan Laboratories
13.9.1 Mylan Laboratories Company Information
13.9.2 Mylan Laboratories Sofosbuvir Tablets Product Portfolios and Specifications
13.9.3 Mylan Laboratories Sofosbuvir Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Mylan Laboratories Main Business Overview
13.9.5 Mylan Laboratories Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Sofosbuvir Tablets Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Sofosbuvir Tablets Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Original Drugs
Table 4. Major Players of Generic Drugs
Table 5. Global Sofosbuvir Tablets Sales by Type (2018-2023) & (K Boxes)
Table 6. Global Sofosbuvir Tablets Sales Market Share by Type (2018-2023)
Table 7. Global Sofosbuvir Tablets Revenue by Type (2018-2023) & ($ million)
Table 8. Global Sofosbuvir Tablets Revenue Market Share by Type (2018-2023)
Table 9. Global Sofosbuvir Tablets Sale Price by Type (2018-2023) & (US$/Box)
Table 10. Global Sofosbuvir Tablets Sales by Application (2018-2023) & (K Boxes)
Table 11. Global Sofosbuvir Tablets Sales Market Share by Application (2018-2023)
Table 12. Global Sofosbuvir Tablets Revenue by Application (2018-2023)
Table 13. Global Sofosbuvir Tablets Revenue Market Share by Application (2018-2023)
Table 14. Global Sofosbuvir Tablets Sale Price by Application (2018-2023) & (US$/Box)
Table 15. Global Sofosbuvir Tablets Sales by Company (2018-2023) & (K Boxes)
Table 16. Global Sofosbuvir Tablets Sales Market Share by Company (2018-2023)
Table 17. Global Sofosbuvir Tablets Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Sofosbuvir Tablets Revenue Market Share by Company (2018-2023)
Table 19. Global Sofosbuvir Tablets Sale Price by Company (2018-2023) & (US$/Box)
Table 20. Key Manufacturers Sofosbuvir Tablets Producing Area Distribution and Sales Area
Table 21. Players Sofosbuvir Tablets Products Offered
Table 22. Sofosbuvir Tablets Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Sofosbuvir Tablets Sales by Geographic Region (2018-2023) & (K Boxes)
Table 26. Global Sofosbuvir Tablets Sales Market Share Geographic Region (2018-2023)
Table 27. Global Sofosbuvir Tablets Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Sofosbuvir Tablets Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Sofosbuvir Tablets Sales by Country/Region (2018-2023) & (K Boxes)
Table 30. Global Sofosbuvir Tablets Sales Market Share by Country/Region (2018-2023)
Table 31. Global Sofosbuvir Tablets Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Sofosbuvir Tablets Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Sofosbuvir Tablets Sales by Country (2018-2023) & (K Boxes)
Table 34. Americas Sofosbuvir Tablets Sales Market Share by Country (2018-2023)
Table 35. Americas Sofosbuvir Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Sofosbuvir Tablets Revenue Market Share by Country (2018-2023)
Table 37. Americas Sofosbuvir Tablets Sales by Type (2018-2023) & (K Boxes)
Table 38. Americas Sofosbuvir Tablets Sales by Application (2018-2023) & (K Boxes)
Table 39. APAC Sofosbuvir Tablets Sales by Region (2018-2023) & (K Boxes)
Table 40. APAC Sofosbuvir Tablets Sales Market Share by Region (2018-2023)
Table 41. APAC Sofosbuvir Tablets Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Sofosbuvir Tablets Revenue Market Share by Region (2018-2023)
Table 43. APAC Sofosbuvir Tablets Sales by Type (2018-2023) & (K Boxes)
Table 44. APAC Sofosbuvir Tablets Sales by Application (2018-2023) & (K Boxes)
Table 45. Europe Sofosbuvir Tablets Sales by Country (2018-2023) & (K Boxes)
Table 46. Europe Sofosbuvir Tablets Sales Market Share by Country (2018-2023)
Table 47. Europe Sofosbuvir Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Sofosbuvir Tablets Revenue Market Share by Country (2018-2023)
Table 49. Europe Sofosbuvir Tablets Sales by Type (2018-2023) & (K Boxes)
Table 50. Europe Sofosbuvir Tablets Sales by Application (2018-2023) & (K Boxes)
Table 51. Middle East & Africa Sofosbuvir Tablets Sales by Country (2018-2023) & (K Boxes)
Table 52. Middle East & Africa Sofosbuvir Tablets Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Sofosbuvir Tablets Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Sofosbuvir Tablets Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Sofosbuvir Tablets Sales by Type (2018-2023) & (K Boxes)
Table 56. Middle East & Africa Sofosbuvir Tablets Sales by Application (2018-2023) & (K Boxes)
Table 57. Key Market Drivers & Growth Opportunities of Sofosbuvir Tablets
Table 58. Key Market Challenges & Risks of Sofosbuvir Tablets
Table 59. Key Industry Trends of Sofosbuvir Tablets
Table 60. Sofosbuvir Tablets Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Sofosbuvir Tablets Distributors List
Table 63. Sofosbuvir Tablets Customer List
Table 64. Global Sofosbuvir Tablets Sales Forecast by Region (2024-2029) & (K Boxes)
Table 65. Global Sofosbuvir Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Sofosbuvir Tablets Sales Forecast by Country (2024-2029) & (K Boxes)
Table 67. Americas Sofosbuvir Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Sofosbuvir Tablets Sales Forecast by Region (2024-2029) & (K Boxes)
Table 69. APAC Sofosbuvir Tablets Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Sofosbuvir Tablets Sales Forecast by Country (2024-2029) & (K Boxes)
Table 71. Europe Sofosbuvir Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Sofosbuvir Tablets Sales Forecast by Country (2024-2029) & (K Boxes)
Table 73. Middle East & Africa Sofosbuvir Tablets Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Sofosbuvir Tablets Sales Forecast by Type (2024-2029) & (K Boxes)
Table 75. Global Sofosbuvir Tablets Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Sofosbuvir Tablets Sales Forecast by Application (2024-2029) & (K Boxes)
Table 77. Global Sofosbuvir Tablets Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Gilead Sciences, Inc. Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 79. Gilead Sciences, Inc. Sofosbuvir Tablets Product Portfolios and Specifications
Table 80. Gilead Sciences, Inc. Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 81. Gilead Sciences, Inc. Main Business
Table 82. Gilead Sciences, Inc. Latest Developments
Table 83. Shandong Shibo Jindu Pharmaceutical Co., Ltd. Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 84. Shandong Shibo Jindu Pharmaceutical Co., Ltd. Sofosbuvir Tablets Product Portfolios and Specifications
Table 85. Shandong Shibo Jindu Pharmaceutical Co., Ltd. Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 86. Shandong Shibo Jindu Pharmaceutical Co., Ltd. Main Business
Table 87. Shandong Shibo Jindu Pharmaceutical Co., Ltd. Latest Developments
Table 88. CTTQ Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 89. CTTQ Sofosbuvir Tablets Product Portfolios and Specifications
Table 90. CTTQ Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 91. CTTQ Main Business
Table 92. CTTQ Latest Developments
Table 93. Sihuan Pharmaceutical Holdings Group Ltd. Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 94. Sihuan Pharmaceutical Holdings Group Ltd. Sofosbuvir Tablets Product Portfolios and Specifications
Table 95. Sihuan Pharmaceutical Holdings Group Ltd. Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 96. Sihuan Pharmaceutical Holdings Group Ltd. Main Business
Table 97. Sihuan Pharmaceutical Holdings Group Ltd. Latest Developments
Table 98. Cspc Ouyi Pharmaceutical Co., Ltd. Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 99. Cspc Ouyi Pharmaceutical Co., Ltd. Sofosbuvir Tablets Product Portfolios and Specifications
Table 100. Cspc Ouyi Pharmaceutical Co., Ltd. Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 101. Cspc Ouyi Pharmaceutical Co., Ltd. Main Business
Table 102. Cspc Ouyi Pharmaceutical Co., Ltd. Latest Developments
Table 103. Beijing Kawin Technology Share-Holding Co., Ltd. Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 104. Beijing Kawin Technology Share-Holding Co., Ltd. Sofosbuvir Tablets Product Portfolios and Specifications
Table 105. Beijing Kawin Technology Share-Holding Co., Ltd. Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 106. Beijing Kawin Technology Share-Holding Co., Ltd. Main Business
Table 107. Beijing Kawin Technology Share-Holding Co., Ltd. Latest Developments
Table 108. DM Pharma Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 109. DM Pharma Sofosbuvir Tablets Product Portfolios and Specifications
Table 110. DM Pharma Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 111. DM Pharma Main Business
Table 112. DM Pharma Latest Developments
Table 113. Wellona Pharma Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 114. Wellona Pharma Sofosbuvir Tablets Product Portfolios and Specifications
Table 115. Wellona Pharma Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 116. Wellona Pharma Main Business
Table 117. Wellona Pharma Latest Developments
Table 118. Mylan Laboratories Basic Information, Sofosbuvir Tablets Manufacturing Base, Sales Area and Its Competitors
Table 119. Mylan Laboratories Sofosbuvir Tablets Product Portfolios and Specifications
Table 120. Mylan Laboratories Sofosbuvir Tablets Sales (K Boxes), Revenue ($ Million), Price (US$/Box) and Gross Margin (2018-2023)
Table 121. Mylan Laboratories Main Business
Table 122. Mylan Laboratories Latest Developments
List of Figures
Figure 1. Picture of Sofosbuvir Tablets
Figure 2. Sofosbuvir Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Sofosbuvir Tablets Sales Growth Rate 2018-2029 (K Boxes)
Figure 7. Global Sofosbuvir Tablets Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Sofosbuvir Tablets Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Original Drugs
Figure 10. Product Picture of Generic Drugs
Figure 11. Global Sofosbuvir Tablets Sales Market Share by Type in 2022
Figure 12. Global Sofosbuvir Tablets Revenue Market Share by Type (2018-2023)
Figure 13. Sofosbuvir Tablets Consumed in Hospital
Figure 14. Global Sofosbuvir Tablets Market: Hospital (2018-2023) & (K Boxes)
Figure 15. Sofosbuvir Tablets Consumed in Clinic
Figure 16. Global Sofosbuvir Tablets Market: Clinic (2018-2023) & (K Boxes)
Figure 17. Sofosbuvir Tablets Consumed in Other
Figure 18. Global Sofosbuvir Tablets Market: Other (2018-2023) & (K Boxes)
Figure 19. Global Sofosbuvir Tablets Sales Market Share by Application (2022)
Figure 20. Global Sofosbuvir Tablets Revenue Market Share by Application in 2022
Figure 21. Sofosbuvir Tablets Sales Market by Company in 2022 (K Boxes)
Figure 22. Global Sofosbuvir Tablets Sales Market Share by Company in 2022
Figure 23. Sofosbuvir Tablets Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Sofosbuvir Tablets Revenue Market Share by Company in 2022
Figure 25. Global Sofosbuvir Tablets Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Sofosbuvir Tablets Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Sofosbuvir Tablets Sales 2018-2023 (K Boxes)
Figure 28. Americas Sofosbuvir Tablets Revenue 2018-2023 ($ Millions)
Figure 29. APAC Sofosbuvir Tablets Sales 2018-2023 (K Boxes)
Figure 30. APAC Sofosbuvir Tablets Revenue 2018-2023 ($ Millions)
Figure 31. Europe Sofosbuvir Tablets Sales 2018-2023 (K Boxes)
Figure 32. Europe Sofosbuvir Tablets Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Sofosbuvir Tablets Sales 2018-2023 (K Boxes)
Figure 34. Middle East & Africa Sofosbuvir Tablets Revenue 2018-2023 ($ Millions)
Figure 35. Americas Sofosbuvir Tablets Sales Market Share by Country in 2022
Figure 36. Americas Sofosbuvir Tablets Revenue Market Share by Country in 2022
Figure 37. Americas Sofosbuvir Tablets Sales Market Share by Type (2018-2023)
Figure 38. Americas Sofosbuvir Tablets Sales Market Share by Application (2018-2023)
Figure 39. United States Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Sofosbuvir Tablets Sales Market Share by Region in 2022
Figure 44. APAC Sofosbuvir Tablets Revenue Market Share by Regions in 2022
Figure 45. APAC Sofosbuvir Tablets Sales Market Share by Type (2018-2023)
Figure 46. APAC Sofosbuvir Tablets Sales Market Share by Application (2018-2023)
Figure 47. China Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Sofosbuvir Tablets Sales Market Share by Country in 2022
Figure 55. Europe Sofosbuvir Tablets Revenue Market Share by Country in 2022
Figure 56. Europe Sofosbuvir Tablets Sales Market Share by Type (2018-2023)
Figure 57. Europe Sofosbuvir Tablets Sales Market Share by Application (2018-2023)
Figure 58. Germany Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Sofosbuvir Tablets Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Sofosbuvir Tablets Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Sofosbuvir Tablets Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Sofosbuvir Tablets Sales Market Share by Application (2018-2023)
Figure 67. Egypt Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Sofosbuvir Tablets Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Sofosbuvir Tablets in 2022
Figure 73. Manufacturing Process Analysis of Sofosbuvir Tablets
Figure 74. Industry Chain Structure of Sofosbuvir Tablets
Figure 75. Channels of Distribution
Figure 76. Global Sofosbuvir Tablets Sales Market Forecast by Region (2024-2029)
Figure 77. Global Sofosbuvir Tablets Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Sofosbuvir Tablets Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Sofosbuvir Tablets Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Sofosbuvir Tablets Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Sofosbuvir Tablets Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界のソホスブビル錠剤市場予測 2023年-2029年] (コード：LP23DC10546)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のソホスブビル錠剤市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のバクロフェン錠剤市場予測 2023年-2029年
  • 世界のバクロフェン錠剤市場予測 2023年-2029年
  • 世界の塩酸オキシコドン徐放性錠剤市場予測 2023年-2029年
  • 世界のニトレンジピン錠市場予測 2023年-2029年
  • 世界のチカグレロル錠市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆